Article PDF
Avoid common mistakes on your manuscript.
References
Marincola F M. Translational medicine: a two-way road. J Transl Med, 2003, 24: 1
Jiang C Y. Translational medicine in China I: Perspectives from Chinese physicians and scientists. Sci China Life Sci, 2011, 54: 1071–1073
Planas A M, Traystman R J. Advances in translational medicine 2010. Stroke, 2011, 42: 283–284
Moskowitz M A, Lo E H, Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron, 2010, 67: 181–198
Schwartz M, Shechter R. Systemic inflammatory cells fight off neurode-generative disease. Nat Rev Neurol, 2010, 6: 405–410
Abe T, Shimamura M, Jackman K, et al. Key role of CD36 in Toll-like receptor 2 signaling in cerebralischemia. Stroke, 2010, 41: 898–904
Zhang Z Q, Chen H Z, Liu D P. Translational research: Lessons from past research, growing up nowadays, and development goal in future. Sci China Life Sci, 2011, 54: 1085–1088
Li N S. Liu Shih-Hao: Pioneer of translational medicine in China. Sci China Life Sci, 2011, 54: 1089–1095
Chen Z, Zhou G B. Translational medicine should translate medical science and technology into health care for everyone in China. Sci China Life Sci, 2011, 54: 1074–1076
Wang X, Wang E, Marincola F M. Translational medicine is developing in China: a new venue for collaboration. J Transl Med, 2011, 9: 3
Liu Q, Zhang X S, Zeng Y X. Targeted and personalized therapy for cancer: Theory and practice in China. Sci China Life Sci, 2011, 54: 1081–1084
Zeng G Q, Zhong N S. Translational medicine: What is in a name from the perspective of Chinese clinicians? Sci China Life Sci, 2011, 54: 1077–1080
Artemisinin antimalaria coordinating research group. Artemisinin: a novel sesquiterpene lactone (in Chinese). Chin Sci Bull, 1977, 3: 142
Zhang T D, Zhang P F, Wang S R, et al. A preliminary clinical observation with use of ailing injection in 6 cases of leukemia (in Chinese). Heilongjiang Med, 1973, 3: 66–67
Chen L, He Z, Qin L, et al. Antitumor effect of malaria parasite infection in a murine Lewis lung cancer model through induction of innate and adaptive immunity. PLoS ONE, 2011, 6: e24407
Mankoff S P, Brander C, Ferrone S, et al. Lost in translation: obstacles to translational medicine. J Transl Med, 2004, 2: 14
Littman B H, Di Mario L, Plebani M, et al. What’s next in translational medicine? Clin Sci (Lond), 2007, 112: 217–227
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published with open access at Springerlink.com
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Leng, F. Build a two-way road for health industry: the current circumstance of translational medicine in China. Sci. China Life Sci. 55, 931–932 (2012). https://doi.org/10.1007/s11427-012-4377-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-012-4377-9